TMCnet News
Uptrend Call Working As BioMarin Pharmaceutical Stock Rises 16.7% (BMRN)Feb 05, 2013 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for BioMarin Pharmaceutical (NASDAQ:BMRN) on November 5th, 2012 at $47.76. In approximately 3 months, BioMarin Pharmaceutical has returned 16.72% as of today's recent price of $55.74. In the past 52 weeks, shares of BioMarin Pharmaceutical have traded between a low of $31.91 and a high of $56.71 and are now at $55.74, which is 75% above that low price. The 200-day and 50-day moving averages have moved 0.81% higher and 0.83% higher over the past week, respectively. BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of BioMarin Pharmaceutical shares.Log in and add BioMarin Pharmaceutical (BMRN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |